Biblio Discovery — Demo Discovery Service

5 hasil untuk "Hejun Liu"

Menampilkan 1–5 · 0,44 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Structural basis of a shared antibody response to SARS-CoV-2

    Meng Yuan; Hejun Liu; Nicholas C. Wu dkk.

    Science · 2020 · Inggris · OpenAlex Scopus

    Molecular understanding of neutralizing antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could accelerate vaccine design and drug discovery. We analyzed 294 anti-SARS-CoV-2 antibodies and found that immunoglobulin G heavy-chain variable region 3-53 (IGHV3-53) is…

  2. Artikel Jurnal Teks lengkap

    Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity

    Hejun Liu; Nicholas C. Wu; Meng Yuan dkk.

    Immunity · 2020 · Inggris · OpenAlex Scopus

    Most antibodies isolated from individuals with coronavirus disease 2019 (COVID-19) are specific to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, COVA1-16 is a relatively rare antibody that also cross-neutralizes SARS-CoV. Here, we determined a crystal structure of the…

  3. Artikel Jurnal Teks lengkap

    Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants

    Meng Yuan; Deli Huang; Chang-Chun David Lee dkk.

    Science · 2021 · Inggris · OpenAlex Scopus

    are mutated in variants first described in South Africa (B.1.351) and Brazil (P.1). We analyzed their effects on angiotensin-converting enzyme 2 binding, as well as the effects of two of these mutations (K417N and E484K) on nAbs isolated from COVID-19 patients. Binding and neutralization of the two…

  4. Artikel Jurnal Teks lengkap

    Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape

    Paul-Albert Koenig; Hrishikesh Das; Hejun Liu dkk.

    Science · 2021 · Inggris · OpenAlex Scopus

    The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread, with devastating consequences. For passive immunization efforts, nanobodies have size and cost advantages over conventional antibodies. In this study, we generated four neutralizing nanobodies…

  5. Artikel Jurnal Teks lengkap

    A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model

    Jakob Kreye; S. Momsen Reincke; Hans‐Christian Kornau dkk.

    Cell · 2020 · Inggris · OpenAlex Scopus

    The emergence of SARS-CoV-2 led to pandemic spread of coronavirus disease 2019 (COVID-19), manifesting with respiratory symptoms and multi-organ dysfunction. Detailed characterization of virus-neutralizing antibodies and target epitopes is needed to understand COVID-19 pathophysiology and guide…